Ikena is a publicly traded company that is advancing multiple clinical-stage targeted oncology treatments.

Corporate Profile

Ikena Oncology® develops differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. Ikena aims to utilize their depth of institutional knowledge and breadth of tools to efficiently develop the right drug using the right modality for the right patient.

Company Presentation

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Scroll to Top